![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Triage Stroke Panel PMA Accepted for Review by FDA
Triage Stroke Panel PMA Accepted for Review by FDA
February 23, 2005
Biosite, a research-based provider of novel, rapid medical diagnostics, announced the FDA has notified the company that the agency has accepted the Triage Stroke Panel premarket approval application (PMA) for further review. The panel is intended to be used as an aid in the assessment and diagnosis of cerebral ischemia (stroke). The Triage Stroke Panel consists of multiple biomarkers and utilizes a proprietary algorithm to calculate a single MultiMarker Index result.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/02-21-2005/0003064966&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct